Grubaugh, Nathan D.

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 2,074

Sex differences in immune responses that underlie COVID-19 disease outcomes

Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,459

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Quick, J., Grubaugh, N. D., Pullan, S. T., Claro, I. M., Smith, A. D., Gangavarapu, K., Oliveira, G., Robles-Sikisaka, R., Rogers, T. F., Beutler, N. A., et al. (2017) · Nature Protocols

Mosquito-borne diseases and controlGenomics and Phylogenetic Studies

Cited by 1,190

Establishment and cryptic transmission of Zika virus in Brazil and the Americas

Faria, N. R., Quick, J., Claro, I. M., Thézé, J., de Jesus, J. G., Giovanetti, M., Kraemer, M. U. G., Hill, S. C., Black, A., da Costa, A. C., et al. (2017) · Nature

Mosquito-borne diseases and controlViral Infections and Vectors

Cited by 616

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

Pérez-Then, E., Lucas, C., Monteiro, V. S., Miric, M., Brache, V., Cochon, L., Vogels, C. B. F., Malik, A. A., De la Cruz, E., Jorge, A., et al. (2022) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 401

Genomic epidemiology reveals multiple introductions of Zika virus into the United States

Grubaugh, N. D., Ladner, J. T., Kraemer, M. U. G., Dudas, G., Tan, A. L., Gangavarapu, K., Wiley, M. R., White, S., Thézé, J., Magnani, D. M., et al. (2017) · Nature

Mosquito-borne diseases and controlViral Infections and Vectors

Cited by 353

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons

Kissler, S. M., Fauver, J. R., Mack, C., Tai, C. G., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Metti, J., Khullar, G., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 335

Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium Infection

Ma, S., Cahalan, S., LaMonte, G., Grubaugh, N. D., Zeng, W., Murthy, S. E., Paytas, E., Gamini, R., Lukacs, V., Whitwam, T., et al. (2018) · Cell

Erythrocyte Function and PathophysiologyMalaria Research and Control

Cited by 250

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Lucas, C., Vogels, C. B. F., Yildirim, I., Rothman, J. E., Lu, P., Monteiro, V., Gehlhausen, J. R., Campbell, M., Silva, J., Tabachnikova, A., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 226

Contribution of climate change to the spatial expansion of West Nile virus in Europe

Erazo, D., Grant, L., Ghisbain, G., Marini, G., Colón-González, F. J., Wint, W., Rizzoli, A., Van Bortel, W., Vogels, C. B. F., Grubaugh, N. D., et al. (2024) · Nature Communications

Mosquito-borne diseases and controlClimate Change and Health Impacts

Cited by 151

Public health actions to control new SARS-CoV-2 variants

Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A. L., & Cevik, M. (2021) · Cell

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 147

Multiscale PHATE identifies multimodal signatures of COVID-19

Kuchroo, M., Huang, J., Wong, P., Grenier, J.-C., Shung, D., Tong, A., Lucas, C., Klein, J., Burkhardt, D. B., Gigante, S., et al. (2022) · Nature Biotechnology

Single-cell and spatial transcriptomicsTopological and Geometric Data Analysis

Cited by 72